arformoterol
Sign in to saveAlso known as Brovana®, YM-08316, (-)-formoterol, (R,R)-formoterol, (-)-Formoterol
Arformoterol, sold under the brand name Brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD).
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 457140599
- Drug.image
- Arformoterol.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.image2
- Arformoterol ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.USAN
- Arformoterol tartrate
- Drug.tradename
- Brovana
- Drug.MedlinePlus
- a602023
- Drug.DailyMedID
- Arformoterol
- Drug.routes_of_administration
- Inhalation
- Drug.ATC_prefix
- None
- Drug.legal_US
- Rx-only
- Drug.protein_bound
- 52–65%
- Drug.elimination_half life
- 26 hours
- Drug.CAS_number
- 67346-49-0
- Drug.PubChem
- 3083544
via Wikipedia infobox
~1 min read
Encyclopedic overview
3 sectionsContents
- Medical uses
- References
- External links
Arformoterol, sold under the brand name Brovana among others, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD).
It is a long-acting β2 adrenoreceptor agonist (LABA) and it is the active (R,R)-(−)-enantiomer of formoterol. It was approved for medical use in the United States in October 2006. It is available as a generic medication.
Excerpted from Wikipedia’s “arformoterol” article, available under the CC BY-SA 4.0 licence.